Publications by authors named "Faith Bartsch"
Mol Cancer Ther
September 2020
Article Synopsis
- Abnormal activity of prolactin (PRL) and its receptor (PRLR) is linked to the progression of uterine cancer, but the mechanisms involved are unclear.
- Analysis of cancer databases revealed that a specific short form of PRLR (PRLR_SF) is overexpressed in uterine cancer compared to non-cancerous tissues.
- Treatment with the PRL antagonist G129R showed promising results in reducing tumor growth, highlighting new potential targets and indicating that G129R may induce cell death through specific cellular pathways in uterine cancer models.
